The SARS–CoV-2 infection has caused both acute and chronic COVID–19 disease during
the recent pandemic with emerging more transmissible SARS–CoV–2 Omicron variants …

For those who have traveled by flight during this pandemic and been seated in a packed
cabin for an extended period, it is natural to worry about the elevated risk of COVID-19 …

SARS-CoV-2 is primarily an airborne infection of the upper respiratory tract, which on
reaching the lungs causes the severe acute respiratory disease, COVID-19. Its first contact …

In the case of current COVID-19, successful prophylactic approaches are likely to have a
greater impact than successful treatment approaches. In this article, we discuss the …

Dear Editor, The COVID-19 pandemic caused by SARS-CoV-2, highly transmissible from
person to person via droplets and small particles inhaled in the upper respiratory tract, leads …

Although vaccines and monoclonal antibody countermeasures have reduced the morbidity
and mortality associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV …

Abstract Unlike conventional Coronavirus 2019 (COVID-19) vaccines, intranasal vaccines
display a superior advantage because the nasal mucosa is often the initial site of infection …

Although vaccines and monoclonal antibody countermeasures have reduced the morbidity
and mortality associated with SARS-CoV-2 infection, variants with constellations of …

The development and deployment of vaccines against COVID-19 demonstrated major
successes in providing immunity and preventing severe disease and death. Yet SARS-CoV …

The recombinant human interferon alpha-2b (IFN-a2b) nasal drop formulation (Nasalferon)
was studied as prophylaxis for SARS-CoV-2. Healthy volunteers between 19 and 80 years …